​

Funding Round

Series E - PacBio

Series E - PacBio

Investment Firm

Overview

PacBio is a biotechnology company that designs, develops, and manufactures sequencing systems.

Announced Date

Jul 14, 2008

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

Intel Capital

Intel Capital

Intel Capital is a convertible_note and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

10

Investor Name
Participant InvestorDAG Ventures
Participant InvestorAlloy Ventures
Participant InvestorKleiner Perkins
Participant InvestorMorgan Stanley
Participant InvestorMohr Davidow Ventures

Round Details and Background

PacBio raised $100000000 on 2008-07-14 in Series E

PacBio is a biotechnology company that designs, develops, and manufactures sequencing systems.

Company Funding History

11

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 31, 2005
Series C - PacBio
3-7.7M
Jul 14, 2010
Series F - PacBio
11-109.0M
Jan 15, 2007
Series D - PacBio
4-50.0M
Oct 01, 2009
Series E - PacBio
14-68.0M

Recent Activity

There is no recent news or activity for this profile.